Steven Paul’s “How to improve R&D productivity: the pharmaceutical industry's grand challenge” published in Nature Reviews Drug Discovery in 2010 is one of the highest cited and most frequently quoted ...

After nearly a decade as No. 1, Roche has finally been knocked off the top spot of our annual list of the biggest research and development budgets in pharma, sent spinning down the ladder by a ...

Pharma’s return on investment (ROI) for research and development (R&D) is seeing a comeback after a record low in 2022, according to a recent report out of Deloitte. ROI on pharma R&D jumped to 4.1% ...

Few media events generate the high TV viewership as does the Academy Awards. While the numbers have been dropping over the years, last Sunday’s event drew 13.7 million viewers and provided a great ...

The biopharmaceutical industry is facing unprecedented challenges to its fundamental business model and currently cannot sustain sufficient innovation to replace its products and revenues lost due to ...

Pharmaceutical research and development (R&D) has become increasingly challenging for various reasons, including the proliferation of plausible targets to pursue for therapeutic innovation resulting ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

SALZBURG, Austria--(BUSINESS WIRE)--Launched as the D-mine ® Pump, this portable micro infusion device recently received European CE approval and is currently being launched in several European ...